Nothing Special   »   [go: up one dir, main page]

GB0721013D0 - New Salts - Google Patents

New Salts

Info

Publication number
GB0721013D0
GB0721013D0 GBGB0721013.1A GB0721013A GB0721013D0 GB 0721013 D0 GB0721013 D0 GB 0721013D0 GB 0721013 A GB0721013 A GB 0721013A GB 0721013 D0 GB0721013 D0 GB 0721013D0
Authority
GB
United Kingdom
Prior art keywords
new salts
salts
new
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0721013.1A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sosei R&D Ltd
Original Assignee
Arakis Ltd
Sosei R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arakis Ltd, Sosei R&D Ltd filed Critical Arakis Ltd
Priority to GBGB0721013.1A priority Critical patent/GB0721013D0/en
Publication of GB0721013D0 publication Critical patent/GB0721013D0/en
Priority to PCT/GB2008/050979 priority patent/WO2009053742A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D267/00—Heterocyclic compounds containing rings of more than six members having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D267/22—Eight-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
GBGB0721013.1A 2007-10-25 2007-10-25 New Salts Ceased GB0721013D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0721013.1A GB0721013D0 (en) 2007-10-25 2007-10-25 New Salts
PCT/GB2008/050979 WO2009053742A2 (en) 2007-10-25 2008-10-23 Salts of nefopam and their use in therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0721013.1A GB0721013D0 (en) 2007-10-25 2007-10-25 New Salts

Publications (1)

Publication Number Publication Date
GB0721013D0 true GB0721013D0 (en) 2007-12-05

Family

ID=38829977

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0721013.1A Ceased GB0721013D0 (en) 2007-10-25 2007-10-25 New Salts

Country Status (2)

Country Link
GB (1) GB0721013D0 (en)
WO (1) WO2009053742A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940911B1 (en) * 2009-01-13 2012-09-21 Philippe Perovitch FORMULATION FOR ORAL TRANSMUCOSAL ADMINISTRATION OF ANTALGIC AND / OR ANTI-SPASMODIC MOLECULES
CN105687185B (en) 2009-12-15 2019-07-09 儿童医院 The method of the disease of invasion fiber type tumor disease and beta-catenin mediation is treated using nefopam compound
US10736905B1 (en) 2016-09-09 2020-08-11 Shahin Fatholahi Nefopam dosage forms and methods of treatment
US10736874B1 (en) 2017-09-08 2020-08-11 Shahin Fatholahi Methods for treating pain associated with sickle cell disease
US11446311B2 (en) 2017-09-08 2022-09-20 Shahin Fatholahi Methods for treating pain associated with sickle cell disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0213869D0 (en) 2002-06-17 2002-07-31 Arakis Ltd The treatment of pain
GB0328871D0 (en) 2003-12-12 2004-01-14 Arakis Ltd Resolution process

Also Published As

Publication number Publication date
WO2009053742A2 (en) 2009-04-30
WO2009053742A3 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
TWI371277B (en) Salt form
GB0720038D0 (en) New compounds
GB0720041D0 (en) New Compounds
IL202616A0 (en) Substituted imidazoheterocycles
ZA201001683B (en) Substituted piperidino-dihydrothienopyrimidines
GB0908772D0 (en) New salts 756
GB0822552D0 (en) New use
GB0705915D0 (en) New use
GB0702456D0 (en) New combination
GB0720503D0 (en) New compound
AP2010005314A0 (en) Nanodispersian
GB0702458D0 (en) Salts 668
GB0704000D0 (en) Salts 670
GB0722769D0 (en) New compounds
GB0701273D0 (en) New compounds
GB2450608B (en) New use
GB0702459D0 (en) Salts 669
GB0702385D0 (en) New combination
GB0702382D0 (en) New salt
HU0700395D0 (en) New compounds
GB0702416D0 (en) New combination
GB0721013D0 (en) New Salts
IL200965A0 (en) Substituted tetrahydropyrroloquinolines
GB0703998D0 (en) Novel salt
GB0714728D0 (en) Salts

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)